ESR1 and breast cancer: Evidence of miR-206 as a tumor growth suppressor has been reported in several cancers: miR-206 was found down-regulated in ERα-positive human breast cancer tissues and transfection of miR-206 into MCF-7 breast cancer cells inhibits cell growth in a dose- and time-dependent manner [30].